Woodline Partners’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,424
| Closed | -$150K | – | 1013 |
|
|
2025
Q1 | $150K | Hold |
17,424
| – | – | ﹤0.01% | 883 |
|
|
2024
Q4 | $623K | Buy |
17,424
+82
| +0.5% | +$2.93K | ﹤0.01% | 812 |
|
|
2024
Q3 | $819K | Sell |
17,342
-41,350
| -70% | -$1.95M | 0.01% | 516 |
|
|
2024
Q2 | $2.95M | Sell |
58,692
-58,693
| -50% | -$2.95M | 0.03% | 384 |
|
|
2024
Q1 | $13.1M | Buy |
+117,385
| New | +$13.1M | 0.12% | 228 |
|
|
2023
Q4 | – | Sell |
-52,080
| Closed | -$1.65M | – | 591 |
|
|
2023
Q3 | $1.65M | Buy |
+52,080
| New | +$1.65M | 0.02% | 413 |
|
|
2023
Q1 | – | Sell |
-20,936
| Closed | -$3.07M | – | 725 |
|
|
2022
Q4 | $3.07M | Buy |
+20,936
| New | +$3.07M | 0.04% | 395 |
|
|
2022
Q3 | – | Sell |
-126,463
| Closed | -$14.6M | – | 796 |
|
|
2022
Q2 | $14.6M | Buy |
+126,463
| New | +$14.6M | 0.23% | 141 |
|
|
2020
Q3 | – | Sell |
-10,686
| Closed | -$6.25M | – | 202 |
|
|
2020
Q2 | $6.25M | Buy |
+10,686
| New | +$6.25M | 0.25% | 96 |
|